Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

Virtual Booth

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

1 API Suppliers, 1 USDMF

1 API Suppliers
1 USDMF

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: Cmt-1, 4-dedimethylaminotetracycline, 2444-65-7, Chembl3622800, 4-des-dimethylaminotetracycline, 4-de-dimethylaminotetracycline

Molecular Formula

C₂₀H₁₉NO₈

Molecular Weight

401.4 g/mol

InChI Key

XCCHQGIGHCRZOS-KBKZQPOHSA-N

1 2D Structure

4-Des-Dimethylaminotetracycline

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

(4aS,5aS,6S,12aR)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide

2.1.2 InChI

InChI=1S/C20H19NO8/c1-19(28)8-3-2-4-10(22)12(8)15(24)13-9(19)5-7-6-11(23)14(18(21)27)17(26)20(7,29)16(13)25/h2-4,7,9,22,24,26,28-29H,5-6H2,1H3,(H2,21,27)/t7-,9-,19+,20-/m0/s1

2.1.3 InChI Key

XCCHQGIGHCRZOS-KBKZQPOHSA-N

2.1.4 Canonical SMILES

CC1(C2CC3CC(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)O

2.1.5 Isomeric SMILES

C[C@@]1([C@H]2C[C@H]3CC(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)O

2.2 Synonyms

2.2.1 MeSH Synonyms

1. 4-de-dimethylaminotetracycline

2. 4-dedimethylaminotetracycline

3. 4-des-dimethylaminotetracycline

4. Cmt-1

2.2.2 Depositor-Supplied Synonyms

1. Cmt-1

2. 4-dedimethylaminotetracycline

3. 2444-65-7

4. Chembl3622800

5. 4-des-dimethylaminotetracycline

6. 4-de-dimethylaminotetracycline

7. 4-de(dimethylamino)tetracycline

8. Schembl2614027

9. Bdbm170149

10. Zinc4879584

11. Bdbm50124122

12. (4as,5as,6s,12ar)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide

13. 2-naphthacenecarboxamide, 1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, (4as-(4aalpha,5aalpha,6beta,12aalpha))-

2.3 Create Date

2011-12-26

3 Chemical and Physical Properties

Molecular Formula	C₂₀H₁₉NO₈
Molecular Weight	401.4 g/mol
XLogP3	0.1
Hydrogen Bond Donor Count	6
Hydrogen Bond Acceptor Count	8
Rotatable Bond Count	1
Exact Mass	401.11106656 g/mol
Monoisotopic Mass	401.11106656 g/mol
Topological Polar Surface Area	178 Å²
Heavy Atom Count	29
Formal Charge	0
Complexity	891
Isotope Atom Count	0
Defined Atom Stereocenter Count	4
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

4 Pharmacology and Biochemistry

4.1 MeSH Pharmacological Classification

Matrix Metalloproteinase Inhibitors

Compounds that inhibit the enzyme activity or activation of MATRIX METALLOPROTEINASES. (See all compounds classified as Matrix Metalloproteinase Inhibitors.)

API SUPPLIERS